Article
Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols
2024-08-21
Abstract excerpt
Lentiviral vector-transduced T-cells were approved by the FDA as gene therapy anti-cancer medications. Little is known about the host genetic variation effects on the safety and efficacy of the lentiviral vector gene delivery system. To narrow this knowledge-gap, we characterized hepatic gene delivery by lentiviral vectors across the Collaborative Cross (CC) mouse genetic reference population. For 24 weeks, we per...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 119ebdaf-42ed-505d-b1bf-a960a85dfab5
- DOI
- 10.1101/2024.08.20.608805
